Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00278187 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: volociximab
DRUG: erlotinib hydrochloride

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]